Abstract
The aim of the addition of splenectomy to a D2 gastrectomy in patients with gastric cancer is to achieve R0 resection and to improve patient survival. However, the survival benefit of splenectomy remains uncertain and the associated morbidity and mortality rates may compromise the beneficial effects of splenectomy (1,2). Given splenic hilar lymph node metastasis has not been observed in early gastric cancer (3), researchers have suggested that a splenectomy for the purpose of splenic hilar node clearance should be performed for patients with high suspicion of metastasis near the splenic hilum or direct tumor invasion of the spleen (3-6).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
